Literature DB >> 16055885

Cough and fever in a female with Crohn's disease receiving infliximab.

G Stratakos1, I Kalomenidis, V Papas, K Malagari, A Kollintza, C Roussos, M Anagnostopoulou, O Paniara, S Zakynthinos, S A Papiris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16055885     DOI: 10.1183/09031936.05.00005205

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

Review 1.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

Review 2.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Xiao-Qing Ji; Li-Xia Wang; De-Gan Lu
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 3.  Pulmonary manifestations of Crohn's disease.

Authors:  De-Gan Lu; Xiao-Qing Ji; Xun Liu; Hong-Jia Li; Cai-Qing Zhang
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 4.  Nocardia infections among immunomodulated inflammatory bowel disease patients: A review.

Authors:  Cândida Abreu; Nuno Rocha-Pereira; António Sarmento; Fernando Magro
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

5.  Pulmonary nocardiosis in an adolescent patient with Crohn's disease treated with infliximab: a serious complication of TNF-alpha blockers.

Authors:  Rishi Verma; Ritu Walia; Stephen B Sondike; Raheel Khan
Journal:  W V Med J       Date:  2015 May-Jun

6.  Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review.

Authors:  Sally J Lawrence; Manish Sadarangani; Kevan Jacobson
Journal:  Front Pediatr       Date:  2017-07-24       Impact factor: 3.418

7.  Increased dosage of infliximab is a potential cause of Pneumocystis carinii pneumonia.

Authors:  Takuya Iwama; Aki Sakatani; Mikihiro Fujiya; Kazuyuki Tanaka; Shugo Fujibayashi; Yoshiki Nomura; Nobuhiro Ueno; Shin Kashima; Takuma Gotoh; Junpei Sasajima; Kentaro Moriichi; Katsuya Ikuta
Journal:  Gut Pathog       Date:  2016-02-02       Impact factor: 4.181

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.